Sort
261,768 grants matching “gene therapy”
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA
$2,957,583Dana-Farber Cancer Institute · P01 · FY2000 · CA
Deciphering the role of CD44 astrocytes in Alzheimer's disease
$2,957,210Osama Al Dalahmah · Columbia University Health Sciences · RF1 · FY2025 · AG
Clinical Genomics and Experimental Therapeutics
$2,956,797Falk Lohoff · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
Targeting Replication Stress and DNA Damage Response in Uterine Cancer
$2,955,234Ursula Anne Matulonis · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)
$2,953,770Lorenzo Leggio · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2017 · AA
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
$2,953,179Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2023 · CA
Mitochondrial stress responses in neurodegeneration
$2,952,417Derek Narendra · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Engineering T cells to Provide Durable Control of HIV-1 Replication
$2,951,367James L Riley · University Of Pennsylvania · U19 · FY2017 · AI
Identification of Genes Causing Syndromic and Nonsyndromic Hearing Impairment
$2,951,068Thomas Friedman · National Institute On Deafness And Other Communication Disorders · ZIA · FY2019 · DC
The Immunobiology of Marrow Allografts for Leukemia
$2,949,927Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2006 · CA
Center for Genetic Studies of Drug Abuse in Outbred Rats
$2,949,105Abraham A Palmer · University Of California, San Diego · P50 · FY2019 · DA
GENERAL CLINICAL RESEARCH CENTER
$2,948,573University Of Pennsylvania · M01 · FY2000 · RR
INSPIRE: Innovative Strategies for Personalized Immunotherapies and Reservoir Eradication
$2,948,452R. Brad Jones · Weill Medical Coll Of Cornell Univ · UM1 · FY2025 · AI
SPORE IN BREAST CANCER
$2,948,038University Of Alabama At Birmingham · P50 · FY2002 · CA
Stem Cell Transplantation: Basic/Clinical Research
$2,947,491Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2010 · HL
NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial in patients with retinitis pigmentosa
$2,945,503Xiangrong Kong · Johns Hopkins University · UG1 · FY2024 · EY
University of Washington (UW) Mendelian Genomics Data Coordinating Center
$2,944,042Susanne May · University Of Washington · U24 · FY2022 · HG
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$2,943,796Alan Sher · Niaid Extramural Activities · Z01 · FY2007 · AI
The Immunobiology of Marrow Allografts for Leukemia
$2,943,616Sloan-Kettering Institute For Cancer Res · P01 · FY2005 · CA
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$2,942,898Pablo Tebas · University Of Pennsylvania · UM1 · FY2019 · AI
Hyperthermia and Perfusion Effects in Cancer Therapy
$2,942,626Mark Wesley Dewhirst · Duke University · P01 · FY2009 · CA
Center for Cell Circuits
$2,941,835Aviv Regev · Broad Institute, Inc. · P50 · FY2014 · HG
Developing Pluripotent Stem Cells to Model and Treat Lung Disease
$2,941,211Darrell N. Kotton · Boston University Medical Campus · P01 · FY2024 · HL
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
$2,940,765Zhigang David Luo · University Of California-Irvine · R01 · FY2019 · DE
ID-CTP Clinical Core
$2,939,106Sung-Yun Pai · Division Of Basic Sciences - Nci · ZID · FY2024 · CA